ロード中...
Preparation and radiolabeling of a lyophilized (kit) formulation of DOTA-rituximab with (90)Y and (111)In for domestic radioimmunotherapy and radioscintigraphy of Non-Hodgkin’s Lymphoma
BACKGROUND: On the basis of results of our previous investigations on (90)Y-DTPA-rituximab and in order to fulfil national demands to radioimmunoconjugates for radioscintigraphy and radioimmunotherapy of Non-Hodgkin’s Lymphoma (NHL), preparation and radiolabeling of a lyophilized formulation (kit) o...
保存先:
| 出版年: | Daru |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4261883/ https://ncbi.nlm.nih.gov/pubmed/25074720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2008-2231-22-58 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|